B

Bridgebio Pharma (BBIO)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD

About Bridgebio Pharma (BBIO)

BridgeBio Pharma, Inc. is a United States-based company, The Company discovers and develops medicines that target well-characterized genetic diseases. The Company’s product platform divided into three key categories: Mendelian, Oncology and Gene ther... Read more

  • USD9.25
  • USD9.39
  • USD8.58
  • USD12.64
  • 16.10%
  • 89M
  • 1.10M
  • 1.36M
  • 1.3B
  • 4.98
  • -10.70%

More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.